Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 4 of 7)

September 16, 2021 updated by: University of Bern

Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach

NOTE: This is the fourth of in total 7 sub-studies related to the Ethics Committee of the Canton of Bern Ref. No. KEK-BE 2016-00674. This sub-study includes 50 participants and 8 arms, in total 350 participants will be assessed in all 7 sub-studies.

General study information: This is a randomized, cross-over, quantitative study, which investigates physiological variables, mood, and affect of healthy participants in response to colored light exposure. The Participants take part in 5-8 arms and are exposed to colored light only, or are additionally asked to solve cognitive tasks during the colored light exposure. Primary aim is to measure the change in several physiological variables, mood, and affect during colored light exposure of 15 or 45 minutes. The risk for the participants is negligible and comparable to the risk during daily life.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3012
        • University of Bern, Institute of Complementary Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Normal color vision
  • Right handed
  • Written informed consent

Exclusion Criteria:

  • Smoking
  • Any kind of diagnosed sleep disorder or neurological or psychiatric disorder in the last 3 months
  • Acute severe traumas
  • Chronic diseases with the necessity for medication
  • Use of recreational drugs
  • Regular intake of medication that would affect the outcome measures
  • Regular excessive alcohol use (> 18 standard units / week)
  • Transmeridian travel in the last month (crossed > 1 time zone border)
  • Night shift word during the last month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Visible light exposure cognitive Red
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to red LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive Orange
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to orange LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive Yellow
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to yellow LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive Green
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to green LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive Cyan
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to cyan LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive Blue
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to blue LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive Violet
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to violet LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.
Experimental: Visible light exposure cognitive White
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to white LED light at a fixed illuminance for 15 minutes. The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness. The participants will additionally perform hyperventilation and hypoventilation tasks.
Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cerebral tissue oxygen saturation during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change in variables of the heart rate variability during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change in variables of the electro-dermal activity during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change of the blood pressure during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change of the partial pressure of carbon dioxide during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change of the respiration rate during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change of the heart rate during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change of the pulse-respiratory quotient during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
The pulse-respiratory quotient will be calculated as heart rate divided by the respiration rate.
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change of the arterial oxygen saturation during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
Change in cerebral hemoglobin concentrations during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in verbal fluency task performance during exposure to different colors.
Time Frame: 1-4 weeks
A word repetition task will serve as control condition.
1-4 weeks
Change in arithmetic task performance during exposure to different colors.
Time Frame: 1-4 weeks
A word repetition task will serve as control condition.
1-4 weeks
Difference in brain activity evoked from the verbal fluency task for the different colored light conditions.
Time Frame: 1-4 weeks
A word repetition task will serve as control condition.
1-4 weeks
Difference in brain activity evoked from the arithmetic task for the different colored light conditions.
Time Frame: 1-4 weeks
A word repetition task will serve as control condition.
1-4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ursula Wolf, Prof. Dr., University of Bern

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 18, 2017

Primary Completion (Actual)

October 8, 2018

Study Completion (Actual)

January 18, 2020

Study Registration Dates

First Submitted

August 24, 2016

First Submitted That Met QC Criteria

September 27, 2016

First Posted (Estimate)

September 29, 2016

Study Record Updates

Last Update Posted (Actual)

September 17, 2021

Last Update Submitted That Met QC Criteria

September 16, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Access to research data and documents will be handled according to the Manifesto to advance Data Access and Research Transparency (DART) in Switzerland, formulated at the workshop on "Improving DART in Switzerland" in Bern, November 7th, 2014.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe